North America Contraceptive Drugs Market Size, Share and Growth Forecast for 2025 – 2032

North America Contraceptive Drugs Market by Type (Oral Contraceptives, Injectable, Implants), Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospitals & Clinics), and Country Analysis from 2025 to 2032

ID: PMRREP34967

Format: PPT*, PDF, EXCEL

Last Updated: 18 Jun 2025

Industry: Healthcare

Number of Pages: 188

Persistence Market Research Report, Market Growth and Regional Outlook

Table of Content

  1. Executive Summary
    1. North America Contraceptive Drugs Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Technology Assessment
    3. Type Adoption / Usage Analysis
    4. Key Market Players
    5. Regulatory Landscape
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. North America Contraceptive Drugs Market Outlook
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2023
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2024–2032
    3. North America Contraceptive Drugs Market Outlook: Type
      1. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2023
      2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2024–2032
        1. Oral Contraceptives
        2. Injectable
        3. Implants
      3. Market Attractiveness Analysis: Type
    4. North America Contraceptive Drugs Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
      2. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024–2032
        1. Retail Pharmacies
        2. Online Pharmacies
        3. Hospitals & Clinics
      3. Market Attractiveness Analysis: Distribution Channel
  5. North America Contraceptive Drugs Market Outlook: Country
    1. Historical Market Size (US$ Bn) Analysis, By Country, 2019-2023
    2. Current Market Size (US$ Bn) and Forecast Analysis, By Country, 2024–2032
      1. U.S.
      2. Canada
    3. Market Attractiveness Analysis: Country
  6. U.S. Contraceptive Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Type
      2. By Distribution Channel
    2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2024–2032
      1. Oral Contraceptives
      2. Injectable
      3. Implants
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024–2032
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Hospitals & Clinics
    4. Market Attractiveness Analysis
  7. Canada Contraceptive Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
      1. By Type
      2. By Distribution Channel
    2. Current Market Size (US$ Bn) and Forecast Analysis, By Type, 2024–2032
      1. Oral Contraceptives
      2. Injectable
      3. Implants
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024–2032
      1. Retail Pharmacies
      2. Online Pharmacies
      3. Hospitals & Clinics
    4. Market Attractiveness Analysis
  8. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping by Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Church & Dwight Co., Inc.
        1. Overview
        2. Segments and Sources
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Reckitt Benckiser Group Plc
      3. Veru, Inc.
      4. Organon Group of Companies
      5. Pfizer, Inc.
      6. Teva Pharmaceutical Industries Ltd.
      7. The Cooper Companies, Inc.
      8. Mayer Laboratories, Inc.
      9. Agile Therapeutics
      10. TherapeuticsmMD, Inc.
      11. Bayer Ag
      12. Afaxys, Inc.
      13. Mithra Pharmaceuticals
      14. Abbvie
      15. Others
  9. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate